Literature DB >> 16287651

Voice disorders and gastroesophageal reflux.

Maja Sereg-Bahar1, Rado Jansa, Irena Hocevar-Boltezar.   

Abstract

Gastroesophageal reflux (GER) can cause serious voice problems and laryngopharyngeal disorders influencing the patient's quality of life. Forty-three patients with suspected laryngopharyngeal reflux (LPR) were included into a prospective study. The diagnosis was made on the basis of the patient's history, the videoendolaryngoscopy, the oesophago-gastroscopy and the biopsy of the oesophageal mucosa. All the LPR patients were treated with esomeprasol for eight weeks. An acoustic analysis of the vowel /a/ samples was performed in the LPR group before and after the treatment. Thirty-six patients with vocal fold polyps served as the control group for a subjective estimation of the voice problems. All the patients from both groups subjectively evaluated their voice problems using the Voice Handicap Index (VHI) questionnaire. The results of VHI showed that the severity of the voice problems of the patients with LPR could be compared to that experienced by the patients with vocal fold polyps. Videoendolaryngoscopy and history proved LPR in all 43 patients. Oesophago-gastroscopy combined with the histopathological examination of the oesophageal biopsy specimens detected signs of possible GER in 38 patients (88%). The results of the videoendolaryngoscopy combined with a subjective and objective voice assessment, performed before and after treatment with a proton-pump inhibitor, showed a significant improvement in most of the studied parameters by the end of the therapy. In the diagnostics of LPR, the patient's history and videoendolaryngoscopy demonstrated to be superior to oesophago-gastroscopy. Videoendolaryngoscopic assessment of the laryngeal mucosa, and oesophago-gastroscopy supplemented with a biopsy of the oesophageal mucosa, showed to be a convenient diagnostic method when GER and LPR were suspected. Esomeprasol proved to be very effective in the treatment of LPR. LPR should not be overlooked in the treatment of dysphonic patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16287651     DOI: 10.1080/14015430500320182

Source DB:  PubMed          Journal:  Logoped Phoniatr Vocol        ISSN: 1401-5439            Impact factor:   1.487


  7 in total

1.  [Laryngectomised patients with voice prostheses: influence of supra-esophageal reflux on voice quality and quality of life].

Authors:  K J Lorenz; L Grieser; T Ehrhart; H Maier
Journal:  HNO       Date:  2011-02       Impact factor: 1.284

Review 2.  Gender differences affecting vocal health of women in vocally demanding careers.

Authors:  Eric J Hunter; Kristine Tanner; Marshall E Smith
Journal:  Logoped Phoniatr Vocol       Date:  2011-07-04       Impact factor: 1.487

3.  Normative Values of Client-Reported Outcome Measures and Self-Ratings of Six Voice Parameters via the VoiceEvalU8 App.

Authors:  Elizabeth U Grillo; Brigit Corej; Jeremy Wolfberg
Journal:  J Voice       Date:  2021-12-09       Impact factor: 2.300

4.  Association Between Voice Handicap Index and Reflux Symptom Index: A cross-sectional study of undiagnosed general and teacher cohorts in Saudi Arabia.

Authors:  Rawan Alanazi; Ahmed Alrahim; Sara Bayounos; Abdulrahman Al-Ghuwainem; Mohammad H Al-Bar
Journal:  Sultan Qaboos Univ Med J       Date:  2018-12-19

5.  Effects of omeprazole over voice quality in muscle tension dysphonia patients with laryngopharyngeal reflux.

Authors:  Tolga Kandogan; Gökce Aksoy; Abdullah Dalgic
Journal:  Iran Red Crescent Med J       Date:  2012-12-06       Impact factor: 0.611

6.  Treatment of laryngopharyngeal reflux disease: A systematic review.

Authors:  Jerome R Lechien; Francois Mouawad; Maria R Barillari; Andrea Nacci; Seyyedeh Maryam Khoddami; Necati Enver; Sampath Kumar Raghunandhan; Christian Calvo-Henriquez; Young-Gyu Eun; Sven Saussez
Journal:  World J Clin Cases       Date:  2019-10-06       Impact factor: 1.337

7.  Presence of pepsin in laryngeal tissue and saliva in benign and malignant neoplasms.

Authors:  Željko Zubčić; Tihana Mendeš; Andrijana Včeva; Hrvoje Mihalj; Vjeran Bogović; Stjepan Grga Milanković
Journal:  Biosci Rep       Date:  2020-11-27       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.